| 000 | 01492 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513082424.0 | ||
| 264 | 0 | _c19930630 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0142-2782 | ||
| 024 | 7 |
_a10.1002/bdd.2510140405 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang-Liu, D D | |
| 245 | 0 | 0 |
_aDisposition of SK&F L-190144 in rats and monkeys after oral, intravenous or ocular administration. _h[electronic resource] |
| 260 |
_bBiopharmaceutics & drug disposition _cMay 1993 |
||
| 300 |
_a313-24 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAniline Compounds _xadministration & dosage |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHalf-Life |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aIntestinal Absorption |
| 650 | 0 | 4 | _aMacaca fascicularis |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 |
_aPyrones _xadministration & dosage |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 | _aSpecies Specificity |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aRichman, J B | |
| 700 | 1 | _aLin, P | |
| 700 | 1 | _aSelim, S | |
| 773 | 0 |
_tBiopharmaceutics & drug disposition _gvol. 14 _gno. 4 _gp. 313-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/bdd.2510140405 _zAvailable from publisher's website |
| 999 |
_c8498851 _d8498851 |
||